Barclays
APVO icon

Barclays’s Aptevo Therapeutics APVO Stock Holding History

Barclays’s Portfolio APVO Stock Details APVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Hold
0
– -$283K – 4772
2022
Q2 		– Hold
0
– – – 3231
2022
Q1 		– Hold
0
– – – 3052
2018
Q4 		– Hold
0
– -$105K – 6905
2018
Q3 		– Hold
0
– – – 5493
2018
Q2 		– Hold
0
– – – 5220
2018
Q1 		– Hold
0
– – – 5662
2017
Q4 		– Hold
0
– – – 5347
2017
Q3 		– Hold
0
– – – 6825
2017
Q2 		– Hold
0
– – – 6616
2017
Q1 		– Hold
0
– – – 5719
2016
Q4 		– Hold
0
– – – 6587
2016
Q3 		– Hold
0
– – – 6585

Other funds holding APVO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return